Search for: "Baxter International, Inc." Results 81 - 100 of 220
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jul 2013, 4:00 am by Courtenay Brinckerhoff
Baxter International, Inc., the Federal Circuit interpreted the ex parte reexamination statutes (35 USC §§ 301-307) as providing that the final cancellation of claims in a reexamination proceeding is binding on concurrent litigation proceedings, as long as the litigation... [read post]
8 Jul 2013, 12:00 am
The case commenced when Fresenius USA and Fresenius Medical Care Holdings (collectively, "Fresenius") brought a declaratory judgment action against Baxter International and Baxter Healthcare Corporation (collectively "Baxter") alleging that claims of U.S. [read post]
5 Jul 2013, 5:00 am by Bexis
International Playtex, Inc., 821 F.2d 1438, 1442 (10th Cir. 1987); Foyle v. [read post]
2 Jul 2013, 9:01 am by Lawrence B. Ebert
” (internal citations omitted)). [read post]
28 Jun 2013, 4:49 am by Amber Walsh
Baxter Ventures is a PE fund established by Baxter International Inc. in 2011 to invest up to $200 million in equity in early-stage companies developing therapies that complement Baxter's existing portfolio. [read post]
5 Jun 2013, 5:29 am by Schachtman
Baxter Healthcare, 947 F.Supp. 1387, 1392, 1397, 1403-04 (D. [read post]
2 Apr 2013, 4:00 am by Matthew Tolve
Baxter Int’l., Inc., 495 F.3d 753, 756 (7th Cir. 2007), that CW allegations must be steeply discounted because a purported CW may be lying, have an axe to grind, or not even exist. [read post]
11 Jul 2012, 10:02 pm by Linda Moss
The three drugs in final tests, according to AP, are: Bapineuzumab, from Pfizer Inc. and Johnson & Johnson; Solanezumab, from Eli Lilly & Co.; and Gammagard, from Baxter International Inc. [read post]
16 Jun 2012, 5:48 am by Stephen Jenei
Riedel, Corporate Vice President, Chief Science and Innovation Officer of Baxter International Inc. [read post]
1 Jun 2012, 4:54 am
In fact, our attorneys brought a case against Orion Research Inc. and Baxter Health Care Corporation for a flawed test for the genetic disease cystic fibrosis. [read post]
23 May 2012, 2:56 am by Marie Louise
  Highlights this week included: CAFC: Judge Newman again questions the constitutionality of “do over” patent reexamination: In re Baxter International, Inc (Patents Post-Grant) (WHDA) (Inventive Step) (Patent Docs)   Please join the discussion [...] [read post]
21 May 2012, 9:37 am by Lawrence B. Ebert
Baxter appealed an obviousness finding from a re-examination proceeding. [read post]
21 May 2012, 1:15 am by Scott A. McKeown
” Thus, even a party that was bound by IPX estoppel could file a request for EXP in an attempt to “undo” the effect of an the earlier court judgement, as was the case a few months back in the case of In re Construction Equipment, and again last week in the case of In re Baxter International Inc. [read post]
17 May 2012, 9:59 pm by Patent Docs
Noonan -- In a dissent from the Federal Circuit's affirmance of a Board determination of obviousness, Judge Newman raises a jurisdictional and separation-of-powers argument in In re Baxter International, Inc. that is destined to be decided by the Supreme Court. [read post]